CARBONARA, Giuseppe Gerardo
 Distribuzione geografica
Continente #
NA - Nord America 4.957
AS - Asia 1.935
EU - Europa 1.761
SA - Sud America 492
Continente sconosciuto - Info sul continente non disponibili 152
AF - Africa 62
OC - Oceania 9
Totale 9.368
Nazione #
US - Stati Uniti d'America 4.870
SG - Singapore 759
IT - Italia 529
CN - Cina 484
BR - Brasile 398
SE - Svezia 255
HK - Hong Kong 245
UA - Ucraina 172
FR - Francia 166
DE - Germania 161
RU - Federazione Russa 155
FI - Finlandia 116
VN - Vietnam 104
GB - Regno Unito 97
IN - India 92
BD - Bangladesh 43
CA - Canada 39
AR - Argentina 27
TR - Turchia 27
IR - Iran 26
MX - Messico 25
CI - Costa d'Avorio 22
IQ - Iraq 22
ID - Indonesia 21
CO - Colombia 19
IE - Irlanda 18
SA - Arabia Saudita 17
BE - Belgio 15
EC - Ecuador 13
PH - Filippine 13
ES - Italia 12
JP - Giappone 12
ZA - Sudafrica 12
CZ - Repubblica Ceca 10
CL - Cile 9
JM - Giamaica 9
NL - Olanda 9
PK - Pakistan 9
VE - Venezuela 9
AU - Australia 8
CH - Svizzera 7
KR - Corea 7
LT - Lituania 7
MY - Malesia 7
UZ - Uzbekistan 7
PE - Perù 6
DZ - Algeria 5
JO - Giordania 5
NP - Nepal 5
RO - Romania 5
AT - Austria 4
IL - Israele 4
KE - Kenya 4
KG - Kirghizistan 4
MA - Marocco 4
PL - Polonia 4
RS - Serbia 4
UY - Uruguay 4
BO - Bolivia 3
CR - Costa Rica 3
EG - Egitto 3
HN - Honduras 3
PS - Palestinian Territory 3
PY - Paraguay 3
TT - Trinidad e Tobago 3
A1 - Anonimo 2
BA - Bosnia-Erzegovina 2
DK - Danimarca 2
GE - Georgia 2
KW - Kuwait 2
KZ - Kazakistan 2
MD - Moldavia 2
MM - Myanmar 2
OM - Oman 2
PR - Porto Rico 2
SN - Senegal 2
TN - Tunisia 2
AD - Andorra 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MG - Madagascar 1
MK - Macedonia 1
NG - Nigeria 1
NO - Norvegia 1
Totale 9.210
Città #
Ashburn 424
Jacksonville 395
Fairfield 378
Chandler 369
Woodbridge 362
Singapore 349
San Jose 315
Hong Kong 240
Houston 221
Milan 204
Cambridge 185
Nyköping 182
Ann Arbor 171
Seattle 143
Wilmington 130
Council Bluffs 129
Beijing 105
Dallas 99
Nanjing 93
Lawrence 88
Roxbury 88
Lauterbourg 75
Rome 73
Bari 67
Princeton 67
Boardman 66
Des Moines 59
Los Angeles 56
New York 52
Ho Chi Minh City 42
Inglewood 40
Santa Clara 34
São Paulo 33
Marseille 32
Figino 30
Brooklyn 27
Buffalo 26
Munich 25
Nanchang 24
Helsinki 23
Abidjan 22
Chicago 21
Hanoi 21
Jiaxing 21
Hebei 20
Tianjin 19
Dublin 18
Changsha 16
Orem 16
San Diego 16
Brussels 15
London 15
Toronto 15
Washington 15
Mumbai 14
Rio de Janeiro 14
Chennai 13
Shenyang 13
Istanbul 12
Paris 12
San Francisco 12
Tokyo 12
Turin 12
Columbus 11
Frankfurt am Main 11
Guangzhou 11
Mexico City 11
Augusta 10
Brasília 10
Leawood 10
Belo Horizonte 9
Dearborn 9
Long Beach 9
Stockholm 9
Baghdad 8
Manchester 8
Phoenix 8
Ardabil 7
Atlanta 7
Bologna 7
Dhaka 7
Jeddah 7
Johannesburg 7
Lausanne 7
Medellín 7
North Bergen 7
San Mateo 7
Shanghai 7
Tashkent 7
Turku 7
Wuhan 7
Boydton 6
Buenos Aires 6
Delhi 6
Florence 6
Haikou 6
Jakarta 6
Poplar 6
Porto Alegre 6
Quito 6
Totale 6.171
Nome #
Probiotic and Tea Tree Oil Treatments Improve Therapy of Vaginal Candidiasis: A Preliminary Clinical Study 256
An efficient synthesis of the optically active isomers of 2H-1,4-benzoxazine derivatives, novel KATP channel modulators 210
Convenient synthesis of some 3-phenyl-1-benzofuran-2-carboxylic acid derivatives as new potential inhibitors of CLC-Kb channels 194
Activation and inhibition of kidney CLC-K chloride channels by fenamates 190
Synthesis, in vitro evaluation, and molecular modeling investigation of benzenesulfonimide peroxisome proliferator-activated receptors α antagonists 184
Kidney CLC-K Chloride Channels Show Differential Pharmacological Profiles Depending on the Heterologous Expression System 175
ChemInform Abstract: Convenient Synthesis of Some 3-Phenyl-1-benzofuran-2-carboxylic Acid Derivatives as New Potential Inhibitors of CLC-Kb Channels. 166
2-(9-Antryl)alcanoic acids as chloride channel modulators 164
Synthesis, biological evaluation, and molecular modeling investigation of chiral 2-(4-chloro-phenoxy)-3-phenyl-propanoic acid derivatives with PPARα and PPARγ agonist activity 159
Carboxylic acids and skeletal muscle chloride channel conductance: Effects on the biological activity induced by the introduction of an aryloxyalkyl group α to the carboxylic function of 4-chloro-phenoxyacetic acid 159
Comparative LC Enantioseparation of Novel PPAR Agonists on Cellulose- and Amylose-Based Chiral Stationary Phases 155
Repositioning of Endonuclear Receptors Binders as Potential Antibacterial and Antifungal Agents. Eptyloxìm: A Potential and Novel Gyrase B and Cytochrome Cyp51 Inhibitor 147
Carbonic anhydrase inhibitors are specific openers of skeletal muscle BK channel of K+ - deficient rats 144
AGONISTI DEI RECETTORI NUCLEARI PPARs COME POTENZIALI NUOVI AGENTI TERAPEUTICI PER IL TRATTAMENTO DELLA SINDROME METABOLICA. 135
Elucidation of the synergistic action of Mentha Piperita essential oil with common antimicrobials 134
Molecular determinants for the activating/blocking actions of the 2H-1,4-benzoxazine derivatives, a class of potassium channel modulators targeting the skeletal muscle KATP channels 133
Agonisti dei Recettori Nucleari PPARs come Potenziali Nuovi Agenti Terapeutici per il Trattamento della Sindrome Metabolica 132
(contributo in convegno) MOLECULAR DETERMINANTS FOR NUCLEAR RECEPTORS SELECTIVITY; CHEMOMETRIC ANALYSIS, DOCKINGS AND SITE-DIRECTED MUTAGENESIS OF DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS α/γ AGONISTS 128
Kidney CLC-K Chloride Channels Inhibitors: Definition of Novel Structural Requirements and Efficacy in CLC-K Polymorphism Associated with Hypertension 125
Design, synthesis and biological evaluation of a class of bioisosteric oximes of the novel dual peroxisome proliferator-activated receptor alpha/gamma ligand LT175 125
Allyphenyline Analogues Potentially Useful in the Management of Chronic Pain and Opioid Addiction 123
Kidney CLC-K chloride channels inhibitors: structure-based studies and efficacy in hypertension and associated CLC-K polymorphisms. 122
Analisi Farmaceutica 121
Chemical studies on Drug Metabolism (part II): N-demethylation and N-oxidation of some alicyclic amines by RuO4 120
MOLECULAR DETERMINANTS FOR NUCLEAR RECEPTORS SELECTIVITY: CHEMOMETRIC ANALYSIS, DOCKINGS AND SITE-DIRECTED MUTAGENESIS OF DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS α/γ AGONISTS 120
Synthesis, Biological Evaluation, and Molecular Modeling Investigation of Chiral Phenoxyacetic Acid Analogues with PPARalpha and PPARgamma Agonist Activity 120
Comparative analysis of enantioselective separation of novel PPAR agonists by HPLC on cellulose- and amylose-based chiral stationary phases 118
Block of renal CLC-K channels by phenoxy-alkyl derivatives of clofibric acid 115
Enantiomeric separation of 2-aryloxyalkyl- and 2-arylalkyl-2-aryloxyacetic acids on a Penicillin G Acylase-based chiral stationary phase: influence of the chemical structure on retention and enantioselectivity 113
Elucidation of the enantioselective recognition mechanism of a penicillin G acylase-based chiral stationary phase towards a series of 2-aryloxy-2-arylacetic acids 108
Attività biologica sui canali KATP del muscolo scheletrico nativo di nuovi e potenti derivati delle 2H-1,4-Benzossazine 108
BIOLOGICAL ACTIVITY OF NEW POTENT 2H-1,4-BENZOXAZINE DERIVATIVES ON THE NATIVE SKELETAL MUSCLE KATP CHANNEL 107
KIDNEY CLC-K CHLORIDE CHANNELS SHOW DIFFERENTIAL PHARMACOLOGICAL PROFILES DEPENDING ON THE HETEROLOGOUS EXPRESSION SYSTEM 106
Exploring the molecular basis of the enantioselective binding of penicillin G acylase towards a series of 2 aryloxyalkanoic acids: A docking and molecular dynamics study 106
Might the observed a2A-adrenoreceptor agonism or antagonism of allyphenyline analogues be ascribed to different molecular conformations? 106
Growth hormone secretagogues exert differential effects on skeletal muscle calcium homeostasis in male rats depending on the peptidyl/non-peptidyl structure 105
Calcium activated K+ channel as a target of prompt-to-use drugs in neuromuscular disorders 102
Structural nucleotide analogs are potent activators/inhibitors of pancreatic beta-cell KATP channels: an emerging mechanism supporting their use as anti-diabetic drugs. 102
Studio delle proprietà enentioselettive di una fase stazionaria chirale a base di PGA 96
Sintesi di una nuova serie di acidi 2-benzofuran-carbossilici a potenziale attività bloccante dei canali al cloro voltaggio-dipendenti CLC-K 95
Molecular determinants for nuclear receptors selectivity: chemometric analysis, dockings and site-directed mutagenesis of dual peroxisome proliferator-activated receptors alpha/gamma agonists 94
Chemical studies on Drug Metabolism: Oxidation with ruthenium tetroxide of some medicinal alicyclic N-metylamines 93
INNOVATIVE METHODOLOGIES IN NANOTECHNOLOGY FOR THE PREVENTION OF BACTERIAL DISEASES 93
Synthesis, biological evaluation and molecular investigation of fluorinated peroxisome proliferator-activated receptors alpha/gamma dual agonists 92
Molecular requisites for drug binding to muscle CLC-1 and renal CLC-K channel revealed by the use of phenoxy-alkyl derivatives of 2-(p-chlorophenoxy)propionic acid 92
Ossidazione di ammine policicliche terziarie con RuO4 90
Molecular switch for CLC-K Cl– channel block/activation: Optimal pharmacophoric requirements towards high-affinity ligands 88
H-1-NMR determination of the enantiomeric excess of the antiarrhythmic drug Mexiletine by using mandelic acid analogues as chiral solvating agents 86
Selective oxidation of nitrogen organic compounds 85
Dimeric analogs of the dual PPARα/γ agonist LT-175: design, synthesis and biological evaluation. 85
Selective oxidation of Nitrogen organic compounds by Ruthenium tetroxide 84
MOLECULAR SPATIAL GEOMETRY OF CLC-K LIGANDS: OPTIMAL REQUIREMENTS TOWARDS HIGH AFFINITY CHANNEL BLOCK. 84
Enantioselective properties of Penicillin G Acylase: Liquid Crhomatographic studies end docking simulations 83
SINTESI E VALUTAZIONE BIOLOGICA DI DERIVATI SEMI-RIGIDI DELL'ACIDO 2-(4-CLOROFENOSSI)-3-FENIL-PROPANOICO COME BLOCCANTI DEI CANALI AL CLORO VOLTAGGIO-DIPENDENTI CLC-K 83
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW ANALOGS OF THE DUAL PPARα/γ AGONIST LT175. 78
Tissue specific action of the 2-(propyl)-1,4-benzoxazine on pancreatic beta cell ATP-sensitive potassium channels 78
NEW CHIRAL CLOFIBRIC ACID ANALOGS AS LIGANDS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) alpha AND gamma 75
Design, synthesis and biological evaluation of a dimeric analog of the dual PPARα/γ agonist 2-(4-phenyl-phenoxy)-3-phenyl-propanoic acid. 74
Determinanti Molecolari della Selettività di Recettori Nucleari: Analisi Chemiometrica e Docking di Agonisti Selettivi di Recettori PPARs 74
Oxidation of tertiary polycyclic amines by RuO4 73
Progettazione e sintesi di nuovi agenti antimicrobici e studio dell'attività biologica in associazione con differenti olii essenziali 72
Effetti sulla conduttanza dei canali al cloro della muscolatura scheletrica indotti dall’introduzione di un sostituente arilossialchilico in a alla funzione carbossilica dell’acido 4-cloro-fenossiacetico 72
EFFETTI DERIVANTI DALL'INTRODUZIONE DI SOSTITUENTI SUL NUCLEO DIFENILICO DEL COMPOSTO LT175, AGONISTA DUALE DEI RECETTORI NUCLEARI PPARalfa E PPARgamma 71
Traduzione Capitoli 1-9 69
Molecular spatial geometry of CLC-K ligands: optimal requirements towards high affinity channel block 69
null 66
Evaluation of biophysical and pharmacological properties of chloride channels belonging to ClC family by the use of chiral clofibric acid derivatives 66
Novel dual PPARalpha/gamma Agonists, as hypoglycemic and antidiabetic agents 66
Dal brodo primordiale alla farmacogenomica 64
Synthesis and biological screening of new chiral a-aryloxy-alkanoic acids as PPARs agonists 64
Synthesis and biological screening of new chiral 2-(4-chloro-phenoxy)-3-phenylpropanoic acid analogs as potential PPAR alpha/gamma dual agonists 63
Synthesis and biological evaluation of new fluorinated analogues with PPARα and PPARγ agonist activity 62
NEW CHIRAL DERIVATIVES OF 2-(4-PHENYL-PHENOXY)-3-PHENYLPROPANOIC ACID WITH PPARalpha/gamma DUAL ACTIVITY. 61
Design, synthesis and biological evaluation of a dimeric analog of the dual PPARα/γ agonist 2-(4-phenyl-phenoxy)-3-phenyl-propanoic acid 61
Effects on skeletal muscle chloride channel conductance of a-aryloxyalkyl-4-chlorophenoxyacetic acids 59
Molecular spatial geometry of CLC-K ligands: optimal requirements towards high affinity channel block 57
null 56
Synthesis and biological screening of new chiral fibrates as potential PPAR α/γ dual agonists 56
Molecular spatial geometry of CLC-K ligands: optimal requirements towards high affinity channel block 53
Dimeric analogs of the dual PPARα/γ agonist LT-175: design, synthesis and biological evaluation 53
sintesi di una nuova serie di acidi 2-benzofuran-carbossilici e valutazione della loro attività bloccante dei canali al cloro voltaggio-dipendenti CLC-K 53
EVALUATION OF BIOPHYSICAL AND PHARMACOLOGICAL PROPERTIES OF CHLORIDE CHANNELS BELONGING TO CLC FAMILY BY THE USE OF CHIRAL CLOFIBRIC ACID DERIVATIVES. 51
PROGETTAZIONE, SINTESI E VALUTAZIONE BIOLOGICA DI DERIVATI OSSIMMINICI AD ATTIVITA’ AGONISTA DUALE PPARα/γ. 50
Novel imidazoline compounds as partial or full agonists of D2-like dopamine receptors inspired by I2-imidazoline binding sites ligand 2-BFI 50
Ureidofibrate-like analogs as PPARgamma Agonists endowed with anti-proliferative activity 49
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW ANALOGS OF THE DUAL PPARalpha/gamma AGONIST LT175 48
MOLECULAR DETERMINANTS FOR NUCLEAR RECEPTORS SELECTIVITY: CHEMIOMETRIC ANALYSIS AND DOCKING OF DUAL PPAR AGONISTS. 47
Synthesis, biological evaluation and molecular modeling investigation of fibrates analogues with PPARalpha945; and PPARgamma47; agonist activity 47
Synthesis and preliminary biological evaluation on PPARs of new ureidofibrate-like analogs 43
Sintesi e valutazione dell’attivita' agonista sui Peroxisome Proliferator-Activated Receptors (PPARs) di una nuova serie di derivati dell’acido 2-fenossi-3-fenil-propanoico 40
null 38
null 37
null 37
null 32
null 30
null 30
null 29
null 27
null 25
null 25
Totale 9.160
Categoria #
all - tutte 37.754
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.754


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022489 0 0 1 22 25 23 29 28 24 27 119 191
2022/20231.064 185 68 60 93 140 146 10 110 214 4 14 20
2023/2024404 26 66 21 25 50 103 23 24 11 11 12 32
2024/20251.257 52 32 124 54 33 82 79 107 61 52 168 413
2025/20262.732 389 178 187 296 233 143 307 81 221 255 71 371
2026/2027352 56 157 139 0 0 0 0 0 0 0 0 0
Totale 9.368